Evidence map›Paper›PMID 35020058›Full record

ArticleSurgical endoscopy2022

Vertical tumor margin of endoscopic resection for T1 colorectal carcinoma affects the prognosis of patients undergoing additional surgery.

Tomoyuki Nishimura, Shiro Oka, Yuki Kamigaichi, Hirosato Tamari, Yasutsugu Shimohara, Yuki Okamoto, Katsuaki Inagaki, Hidenori Tanaka, Ken Yamashita, Ryo Yuge and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. [Prognosis Analysis of Additional Surgical Treatment for High-Risk T1 Colorectal Cancer Patients After Endoscopic Resection].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Tomoyuki NishimuraDepartment of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Shiro OkaDepartment of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. oka4683@hiroshima-u.ac.jp.ORCID http://orcid.org/0000-0002-1773-8293
Yuki KamigaichiDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Hirosato TamariDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Yasutsugu ShimoharaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Yuki OkamotoDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Katsuaki InagakiDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Hidenori TanakaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Ken YamashitaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Ryo YugeDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Yuji UrabeDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Koji ArihiroDepartment of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan.
Fumio ShimamotoFaculty of Health Sciences, Hiroshima Shudo University, Hiroshima, Japan.
Shinji TanakaDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Hiroshima University Hospital · JPHiroshima Shudo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVertical tumor margin-negative T1 colorectal carcinoma (CRC) is an absolute curative condition following complete endoscopic resection (ER). However, the influence on prognosis in relation to vertical tumor margin is unclear. Therefore, we evaluated the influence of the distance from vertical tumor margin to resected specimen edge (vertical margin distance) of ER for T1b (submucosal invasion depth > 1000 μm) CRC on the prognosis of patients undergoing additional surgery after ER.

methodsIn total, 215 consecutive patients with T1b CRC who underwent additional surgery after ER at Hiroshima University Hospital between February 1992 and June 2019 were enrolled. We assessed 191 patients without lymph node metastases at the additional surgery. The specimens resected by ER were classified into three groups based on the vertical margin distance: patients with a vertical margin distance of ≥ 500 μm (Group A); patients with a vertical margin distance of < 500 μm (Group B); and patients with a positive vertical tumor margin (Group C). Subsequently, we evaluated the prognosis of the patients in relation to the clinicopathological characteristics among the three groups.

resultsThere were no significant differences in clinicopathological characteristics among the three groups. Group A had a significantly higher recurrence-free 5-year survival rate than Groups B and C (100%, 84.5%, and 81.8%, respectively). Similarly, Group A had a significantly higher disease-specific 5-year survival rate than Group C (100% vs. 95.5%).

conclusionsComplete en bloc resection with sufficient submucosal layer from the invasive front (vertical margin distance > 500 μm) by ER for T1 CRC reduces the risk of metastatic recurrence after additional surgery.

Indexed as

Colorectal NeoplasmsEndoscopic Mucosal ResectionHumansLymphatic MetastasisMargins of ExcisionNeoplasm Recurrence, LocalPrognosisRetrospective StudiesEndoscopic resectionMetastasis, RecurrenceT1 colorectal carcinomaVertical margin

Identifiers

PMID35020058
OpenAlexW4205804637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.